Clinical Trial Update: "ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 ESTIMATION study evaluating implantation of Endocardial Mesenchymal Stem Cells in patients after acute myocardial infarction; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Endocardial Mesenchymal Stem Cells (endocardial mesenchymal stem cells)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Acute Myocardial Infarction, Heart Failure | Phase 3 | Status: UNKNOWN